Epalrestat Sustained Release Tablets 150mg Manufacturer, Supplier & Exporter in India
Leading Epalrestat 150mg Sustained Release Tablets Manufacturer in India
We at Taj Medico are a well-established manufacturer, exporter, and supplier of Epalrestat Sustained Release Tablets 150mg in India, delivering consistent quality, purity, and pharmaceutical excellence. Our production facility is based in Vapi, Gujarat, and is equipped with advanced manufacturing infrastructure designed to meet stringent international quality standards.
Epalrestat Tablets 150mg are widely used in the management of diabetic neuropathy, a complication of long-standing or poorly controlled diabetes. We ensure that every batch of tablets is manufactured under strict quality control procedures to maintain safety, efficacy, and stability.
Our commitment extends beyond manufacturing—we focus on global healthcare support by supplying high-quality Epalrestat SR Tablets to Africa, the Middle East, Latin America (LTAM), and other regulated and semi-regulated markets.
What is Epalrestat Sustained Release 150mg?
Epalrestat 150mg Sustained Release Tablets belong to a class of medicines known as aldose reductase inhibitors. This medicine is specifically designed to help manage diabetic neuropathy, a condition where prolonged high blood sugar levels damage peripheral nerves.
Diabetic neuropathy commonly results in symptoms such as:
- Burning sensation in limbs
- Tingling and numbness
- Sharp nerve pain
- Reduced sensation in feet and hands
Epalrestat works by inhibiting the aldose reductase enzyme, which reduces the accumulation of sorbitol in nerve cells. This helps in improving nerve function and relieving painful neuropathic symptoms.
Mechanism of Action of Epalrestat Tablets 150mg
We manufacture Epalrestat Sustained Release Tablets with a formulation designed for prolonged action and better patient compliance. The mechanism includes:
- Inhibition of the polyol pathway enzyme aldose reductase
- Reduction of intracellular sorbitol accumulation
- Prevention of osmotic stress in nerve tissues
- Improvement in nerve conduction and metabolic balance
This pharmacological action supports gradual recovery of nerve damage and helps improve quality of life in diabetic patients.
Therapeutic Uses of Epalrestat SR 150mg Tablets
Epalrestat 150mg Tablets are primarily prescribed for:
- Diabetic peripheral neuropathy
- Diabetic nerve pain management
- Tingling and numbness caused by nerve damage
- Supportive therapy in diabetic complications
In some clinical settings, it is also used to support wound healing in diabetic foot conditions by improving microvascular circulation and reducing inflammatory responses.
Dosage and Administration Guidance
We always emphasize that Epalrestat Sustained Release Tablets should be used strictly under medical supervision. The dosage is determined by healthcare professionals based on patient condition.
General usage guidelines include:
- Taken orally with or without food
- Should be consumed at the same time daily for best results
- Sustained release formulation ensures prolonged action
- Continuous usage may be required for several weeks to months
Patients are advised not to discontinue treatment without consulting a doctor, as stopping abruptly may reduce therapeutic benefits.
Benefits of Epalrestat 150mg Sustained Release Tablets
Our Epalrestat SR Tablets provide multiple therapeutic advantages:
- Effective relief from diabetic nerve pain
- Long-lasting sustained release formulation
- Improved nerve function and regeneration support
- Helps reduce burning sensation and numbness
- Supports diabetic complication management
- Enhances patient compliance due to once-daily dosing (as prescribed)
We ensure that every tablet delivers consistent bioavailability and therapeutic reliability.
High-Quality Manufacturing Standards at Taj Medico
We follow strict Good Manufacturing Practices (GMP) and international pharmaceutical guidelines in the production of Epalrestat Tablets 150mg. Our manufacturing process includes:
- High-grade raw material sourcing
- Advanced formulation technology
- Automated production systems
- Stringent in-process quality checks
- Stability and dissolution testing
- Batch-wise documentation and validation
Our quality assurance team ensures that every batch meets required pharmacopoeial standards before release.
Global Exporter of Epalrestat Sustained Release Tablets
We are recognized as a trusted exporter of Epalrestat Tablets 150mg, supplying to multiple international markets, including:
- Africa
- Middle East
- Latin America (LTAM)
- Southeast Asia
- CIS countries
Our export division ensures secure packaging, regulatory compliance, and timely delivery across global destinations.
Packaging and Supply Strength
We offer customized packaging solutions for Epalrestat SR Tablets to meet diverse market requirements. Packaging features include:
- Blister packs for enhanced stability
- Moisture-resistant packaging materials
- Export-compliant labeling
- Bulk packaging for institutional supply
We ensure product integrity throughout storage and transportation.
PCD Pharma Franchise & Business Opportunities
We provide strong business support through our PCD Pharma Franchise model for Epalrestat Sustained Release Tablets 150mg. Our franchise program includes:
- Monopoly-based marketing rights
- Promotional and marketing support
- High-demand product portfolio
- Attractive profit margins
- Timely product supply chain
This enables business partners to grow efficiently in their respective territories.
Why Choose Us as Your Epalrestat Tablets Manufacturer?
We are committed to delivering excellence in pharmaceutical manufacturing and global healthcare supply. Key reasons to choose us include:
- WHO-GMP certified manufacturing facility
- Consistent product quality and stability
- Strong export network across multiple countries
- Experienced R&D and formulation team
- Ethical and transparent business practices
- Customer-focused pharmaceutical solutions
Our goal is to maintain long-term partnerships built on trust, quality, and reliability.
Epalrestat Tablets in Diabetic Neuropathy Management
Diabetic neuropathy is one of the most challenging complications of diabetes, and effective management requires long-term therapy and lifestyle control. Epalrestat 150mg plays an important role in reducing nerve damage progression and improving symptom control.
When combined with proper diabetic management such as diet control, regular exercise, and blood sugar monitoring, Epalrestat contributes significantly to patient well-being.
Safety Profile and Precautions
Epalrestat is generally well tolerated, but in some cases mild side effects may occur such as:
- Nausea
- Vomiting
- Diarrhea
- Mild gastric discomfort
Patients with underlying medical conditions should consult a healthcare professional before use. Continuous monitoring is recommended during long-term therapy.
Commitment to Innovation and Healthcare Excellence
We continuously invest in research and development to improve our formulations and manufacturing processes. Our focus remains on:
- Enhancing drug stability
- Improving patient compliance
- Expanding global access to quality medicines
- Delivering affordable healthcare solutions
Our Epalrestat Sustained Release Tablets 150mg reflect our dedication to innovation and patient-centric pharmaceutical development.
We at Taj Medico stand as a reliable and globally trusted manufacturer, supplier, and exporter of Epalrestat Sustained Release Tablets 150mg in India. With a strong focus on quality, compliance, and international standards, we ensure that every tablet delivers therapeutic effectiveness and patient satisfaction.
Our presence in global pharmaceutical markets continues to expand, driven by our commitment to excellence, affordability, and healthcare improvement. Epalrestat Tablets remain one of our key specialty formulations for diabetic neuropathy management, supporting better health outcomes worldwide.
